Clinical trial NCT06044363: Satir Model for Self-esteem, Mental Health, and Family Function Among Individuals With Substance Use Disorders
Official title: Assessing the Efficacy and Acceptability of the Satir Model on Self-esteem and Mental Health Among Individuals With Substance Use Disorders in China: A Pilot Study Protocol
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Drug Abuse
Self Esteem
Mental Health Wellness 1
Family Dysfunction
Lead sponsor: Hong Kong Metropolitan University
Sponsor class: OTHER
First posted: 2023-09-21
Enrollment: 45
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Intervention model description: a single center, open-label, randomized, controlled trial
Primary purpose: SUPPORTIVE_CARE

Brief summary: Self-esteem and family functioning are associated with mental health and success of drug treatment among individuals with substance use disorders (SUD). The Satir model aims to empower individuals to explore their internal resources, address emotional issues, shift coping strategies, enhancing self-esteem, and develop healthier ways of relating to themselves and others. It offers a range of techniques to enhance self-esteem, challenging negative belief systems, and promote personal growth. The aim of the study is to investigate the acceptability and preliminary efficacy of the Satir model on self-esteem, mental health, and family function among individuals with SUD in China. The study will adopt a mixed-method approach. The quantitative phase will employ a randomized control trial (RCT) utilizing a pre-post study design. The qualitative phase will involve conducting semi-structured individual interviews.The data will be analyzed by using SPSS software package (IBM SPSS statistics version 26.0). The individual-interview will be analyzed by using the six-phase thematic analysis. The study has the potential to advance knowledge in the field of drug rehabilitation interventions, inform evidence-based practice, and improve the wellbeing and outcomes of individual with SUD. It can contribute to the ongoing efforts to address the complex challenges associated with substance use and support individual on their trajectory to recovery.


Eligibility criteria: Inclusion Criteria:

1. aged 18 or above;
2. are able to speak, read, and write Chinese;
3. are willing to participate in the study and share their experience of the intervention with the research group;
4. have informed consent to participate in the study.

Exclusion Criteria:

1. have been diagnosed with severe mental illnesses, such as schizophrenia, mania, antisocial personality disorder;
2. have a diagnosed memory and cognitive impairment;
3. are undergoing psychotherapeutic or psychopharmacologic treatment;
4. are participating in similar studies.

Primary outcomes:
measure: Self-esteem
timeFrame: Through study completion, an average of two months
Secondary outcomes:
measure: Adult attachment
timeFrame: Through study completion, an average of two months
measure: Coping style
timeFrame: Through study completion, an average of two months
measure: Self-efficacy
timeFrame: Through study completion, an average of two months
measure: Meaning in life
timeFrame: Through study completion, an average of two months
measure: Resilience
timeFrame: Through study completion, an average of two months
measure: Positive and negative affect scale
timeFrame: Through study completion, an average of two months
measure: Drug craving
timeFrame: Through study completion, an average of two months
measure: Motivation to abstain from drugs
timeFrame: Through study completion, an average of two months
measure: Family function
timeFrame: Through study completion, an average of two months
Other outcomes:
Locations:
city: Yancheng
country: China
facility: Fangqiang compulsory isolation detoxification center
state: Jiangsu
Study officials:
affiliation: Hong Kong Metropolitan University
name: Haixia Ma, PhD
role: PRINCIPAL_INVESTIGATOR
References: